Operating Lease, Right-of-Use Asset of Lexeo Therapeutics, Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Lexeo Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Lexeo Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $6,963,000, a 17% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Lexeo Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $6,963,000 -$1,472,000 -17% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $7,340,000 -$1,441,000 -16% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $7,708,000 -$1,412,000 -15% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $8,069,000 -$1,373,000 -15% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $8,435,000 -$1,341,000 -14% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $8,781,000 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $9,120,000 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $9,442,000 -$1,266,000 -12% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 $9,776,000 30 Sep 2023 10-Q 11 Dec 2023 2023 Q3
Q4 2022 $10,708,000 31 Dec 2022 10-K 11 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.